Pharmacist Interventions: Improving Adherence to Evidence-Based Therapy

Abstract

Get full access to this article

View all access options for this article.

References

Lorenz

Predictability: does the flap of a butterfly's wings in Brazil set off a tornado in Texas?

AAAS Section on Environmental Sciences, New Approaches to Global Weather: GARP. Boston, Massachussetts, Dec. 29, 1972.

Task Force on a Blueprint for Pharmacy. Blueprint for pharmacy: the vision for pharmacy. Ottawa (ON): Canadian Pharmacists Association; 2008.

Heart and Stroke Foundation. Available: www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/k.34A8/Statistics.htm (accessed August 24, 2009).

Canadian Diabetes Association. The prevalence and costs of diabetes. Available: www.diabetes.ca/about-diabetes/what/prevalence/ (accessed 11 December 2009).

Public Health Agency of Canada. Life and breath: respiratory diseases in Canada. Ottawa (ON): Public Health Agency of Canada; 2007.

Kulkarni

Alexander

Lytle

Long-term adherence with cardiovascular drug regimens. Am Heart J 2006;151:185–91.

Eagle

Kline-Rogers

Goodman

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004;117:73–81.

Spertus

Masoudi

Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842–7.

McAlister

Oreopoulos

Norris

Exploring the treatment-risk paradox in coronary disease. Arch Intern Med 2007;167:1019–25.

10.

Bender

Milgrom

Apter

Adherence intervention research: what have we learned and what do we do next?

J Allergy Clin Immunol 2003;112:489–94.

11.

Krishnan

Reikert

McCoy

Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004;170:1281–5.

12.

Haggerty

Cerulli

Zeolla

Community pharmacy target intervention program to improve aspirin use in persons with diabetes. J Am Pharm Assoc 2005;45:17–22.

13.

Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–60.